<DOC>
	<DOCNO>NCT00435864</DOCNO>
	<brief_summary>Numerous study potential role NK alloreactive n hematopoietic stem cell graft base genotypical analysis KIR receptor genotypic incompatibility KIR HLA couple donor/recipient . There still lot issue non resolve : Are KIR really express occur expression time hematopoietic reconstitution ? Is depend HLA recipient ? If KIR express , mechanism alloreactivity NK cell ? Are NK able lyse tumoral cell ? Could alloreactive NK cell constitute therapeutic tool able induce tolerance elimination leukemia hematopoietic stem cell graft ?</brief_summary>
	<brief_title>Natural Killer Index From Hematopoietic Stem Cell Graft</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Age superior 1 year Patient treat HSC graft Initial pathology recipient : acute lymphoblastic leukemia , acute myeloblastic leukemia , chronic myeloid leukemia Patient already include study exclusion period HIV + HCV + serology pregraft analysis Patient already treat allograft HSC</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>recipient HSC graft Acute Myeloblastic Leukemia therapy</keyword>
	<keyword>recipient HSC graft others pathology treat hematology Nantes university hospital Angers university hospital</keyword>
	<keyword>donor healthy subject</keyword>
</DOC>